Trial Profile
Using behavioral therapy in combination with drug-darifenacin for symptoms of overactive bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2008
Price :
$35
*
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms ABLE
- Sponsors Novartis
- 19 Apr 2008 New trial record.